HomeCCCC • NASDAQ
add
C4 Therapeutics Inc
Previous close
$2.58
Day range
$2.53 - $2.69
Year range
$1.09 - $4.70
Market cap
246.16M USD
Avg Volume
1.53M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 11.23M | -26.90% |
Operating expense | 8.92M | -24.20% |
Net income | -32.17M | -30.41% |
Net profit margin | -286.43 | -78.39% |
Earnings per share | -0.30 | 15.60% |
EBITDA | -23.22M | 16.48% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 191.88M | -24.94% |
Total assets | 265.49M | -29.40% |
Total liabilities | 111.08M | -16.73% |
Total equity | 154.41M | — |
Shares outstanding | 96.91M | — |
Price to book | 1.24 | — |
Return on assets | -21.07% | — |
Return on capital | -26.14% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -32.17M | -30.41% |
Cash from operations | -31.21M | -29.31% |
Cash from investing | 4.09M | 2,422.22% |
Cash from financing | 7.77M | -26.01% |
Net change in cash | -19.35M | -43.69% |
Free cash flow | -23.62M | 5.71% |
About
Founded
2015
Headquarters
Website
Employees
110
